619TiP PIKALO-1: A phase I/II trial of LY4064809 (STX-478), a pan-mutant-selective PI3Kα inhibitor in PIK3CA-mutant (PIK3CAm) advanced breast cancer (ABC) and other solid tumors (Trial in Progress)Antonio Giordano, D. Juric, Komal Jhaveri et al.|Annals of Oncology|2025Cited by 0